HCFA (Health Care Financing Administration) Internet disclosure too open for some companies
This article was originally published in Clinica
The US medical device industry is not uniformly supportive of the Health Care Financing Administration's (HCFA) new attitude of openness. Three companies sent in letters of protest to the agency within 72 hours of the meeting it held recently on proposals to overhaul its Medicare coverage process (see Clinica No 828, p 6), according to Grant Bagley, director of HCFA's coverage and analysis group.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.